28/05/2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Jun »
28/05/2024
May 28, 2024, 14:51 |
Blog
Matt Galsky: Join our growing team at Icahn School of Medicine at Mount Sinai
Matt Galsky, Director of Genitourinary Medical Oncology at Tisch Cancer Institute and Professor of Medicine…
May 28, 2024, 14:49 |
Career
Laura Sánchez Burgos: Nature Communications is looking for another Associate or Senior Editor with a Cancer Genomics background
Laura Sánchez Burgos, Associate Editor at Nature Communications, shared on X: "My team at Nature…
May 28, 2024, 14:42 |
Blog
David Davis: I am so proud the VCU Health Supply Chain team for the recognition from GHX
Arthur Lodge Kellermann, Health Policy Adviser at Virginia Health Workforce Development Authority, shared a post…
May 28, 2024, 14:38 |
Societies
Estela Rodriguez: Keeping up with the press-release literature pre-ASCO24
Estela Rodriguez shared on X: "Keeping up with the press-release literature pre-ASCO24. TROPION-lung01 Datopotamab deruxtecan…
May 28, 2024, 14:34 |
Opinion
Join Dr. Carolina Bernabe for a panel session on Preparing for the Transition from Fellowship at ASCO - Florez Lab
Florez Lab shared a post on X: “Featuring Florez Lab members ASCO24! Join Dr. Carolina Bernabe…
May 28, 2024, 14:34 |
Drugs
Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer
Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…
May 28, 2024, 14:33 |
Societies
Tom Powles: Final results for axitinib/avelumab in 1st line RCC at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X: "Final results for axitinib/avelumab in 1st…
May 28, 2024, 14:25 |
Insight
Luis E. Raez: Sometimes new agents don't have a better OS but they provide benefits
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Stephen Liu on…
May 28, 2024, 14:22 |
Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
May 28, 2024, 14:17 |
Insight
Paolo Cortesi discusses the value of axi-cel as a second-line treatment in patients with R/R LBCL - VJHemOnc
VJHemOnc shared on X: "Paolo Cortesi (The University of Milano-Bicocca) discusses the value of axi-cel as a…
1
2
3
4
5
All:
94
Posts:
11 - 20
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube